We select stocks based on the known investing strategy of select legendary investors. This stock idea scores a 100% rating based on the approach of value investor Benjamin Graham, by John Reese, editor of Validea.
HollyFrontier (HFC) is a petroleum refiner, which produces light products, such as gasoline, diesel fuel, jet fuel, specialty lubricant products, and specialty and modified asphalt.
To meet the Graham criteria, the stock can be neither a technology nor financial company, and therefore this methodology is applicable.
Under this approach, the investor must select companies of adequate size. This includes companies with annual sales greater than $340 million. HFC's sales of $20,358.9 million, based on trailing 12 month sales, pass this test.
The current ratio must be greater than or equal to two. Companies that meet this criterion are typically financially secure and defensive. HFC's current ratio of 2.37 passes the test.
Top 10 Small Cap Stocks To Own Right Now: CarMax Inc(KMX)
CarMax, Inc., through its subsidiaries, operates as a retailer of used vehicles in the United States. It also sells vehicles that do not meet its retail standards to licensed dealers through on-site wholesale auctions, as well as sells new vehicles under franchise agreements. In addition, the company provides customers financing alternatives through its finance operation, CarMax Auto Finance, as well as through its third-party financing providers. Further, it offers a range of other related products and services, including the sale of extended service plans, guaranteed asset protection, and accessories; the appraisal and purchase of vehicles directly from consumers; and vehicle repair services. As of December 21, 2011, the company operated 107 used car superstores in 52 markets. CarMax, Inc. was founded in 1993 and is headquartered in Richmond, Virginia.Advisors' Opinion:
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on CarMax (NYSE: KMX ) , whose recent revenue and earnings are plotted below.
- [By tonyg34]
In a recent interview right here on GuruFocus, Tom Gayner of Markel (MKL) had a few things to say about CarMax (KMX). This prompted me to give the company a closer look. What follows is a business analysis. We will save considerations of stock analysis, such as price, for a later discussion.
I think that is a business that will continue to grow. I don't see any reason why you can't have a Carmax in a lot of towns way beyond what they're talking about right now. I think being the number one dealer, and having the number one market share in used car arena gives you great information on what transaction prices are. Then you work on the process to be as quick and as cost efficient in fixing the car and getting it sold, and have the confidence from customers when you offer warranties on the products. Those factors create a virtuous cycle. The more you do, the more you can do, the better the pricing is, the more the customers like you, the more your brand matters. The company will be around for a good long time. The management has done a very good job of creating the system and executing it.
CarMax was formed as a unit of Circuit City in 1993 and was spun off in 2002. Used-car sales account for about 80% of revenue. Competitors include, but certainly are not limited to, AutoNation (AN) and America's Car-Mart (CRMT) as well as private party sellers.
Top 5 Defensive Stocks To Buy For 2014: Life Technologies Corporation(LIFE)
Life Technologies Corporation operates as a global life sciences company. The company?s Molecular Biology Systems division offers molecular biology-based technologies, including basic and real-time PCR, RNA interference, DNA synthesis, sample preparation, transfection, cloning and protein expression profiling, protein analysis, and thermo-cycler instrumentation technologies. Its Cell Systems division provides cell culture media and sera, stem cells and related tools, cellular imaging products, antibodies, drug discovery services, and cell therapy related products used in the study of cell function. The company?s Genetic Systems division offers capillary electrophoresis systems and reagents, and next generation sequencing systems and reagents comprising SOLiD and Ion Torrent systems, as well as reagent kits developed specifically for applied markets, such as forensics and food safety, pharmaceutical quality monitoring, and animal health markets. Life Technologies Corporat ion also provides repair and maintenance services; and custom services, such as cell line development, custom media modification, and primers and custom assays development services. Its products offer research tools for genomics studies, proteomics studies, gene splicing, cellular analysis, and other research applications required by laboratories associated with universities, medical research centers, and government and other research institutions, as well as biotechnology, pharmaceutical, and chemical companies; and serves clinical labs, medical institutions, medical researchers, and various industries through sales and service professionals, e-commerce capabilities, and onsite supply center solutions. The company was founded in 1987 and is headquartered in Carlsbad, California.Advisors' Opinion:
- [By guruek]
Weekly 52-week high companies: Cigna Corp (CI), Seadrill Ltd (SDRL), Harley-Davidson Inc. (HOG), Life Technologies Corp. (LIFE), and Vodafone Group PLC (VOD).
- [By Alex Planes]
It's been only a few trading days since Illumina surged on a strong earnings report, showing that there's still plenty of life in the sequencing sector. However, competition is only bound to increase now that erstwhile rival Life Technologies (NASDAQ: LIFE ) has found its white knight in Thermo Fisher Scientific (NYSE: TMO ) . I've been optimistic on Life Tech's prospects for some time -- you can read more about my opinions in an analyst debate I held with fellow Fools Travis Hoium and Sean Williams last year -- and that opinion hasn't changed now that Life Tech has even deeper pockets to dip into for research dollars:
- [By Rich Duprey]
As part of its plan to pay for the acquisition of Life Technologies (NASDAQ: LIFE ) , life-sciences specialist Thermo Fisher Scientific (NYSE: TMO ) announced yesterday that it was selling 25.7 million shares at $85.50 per share in a public offering of its stock.
Top 5 Defensive Stocks To Buy For 2014: CME Group Inc.(CME)
CME Group Inc. operates the CME, CBOT, NYMEX, and COMEX regulatory exchanges worldwide. The company provides a range of products available across various asset classes, including futures and options on interest rates, equity indexes, energy, agricultural commodities, metals, foreign exchange, weather, and real estate. It offers various products that provide a means of hedging, speculation, and asset allocation relating to the risks associated with interest rate sensitive instruments, equity ownership, changes in the value of foreign currency, credit risk, and changes in the prices of commodities. CME Group owns and operates clearing house, CME Clearing, which provides clearing and settlement services for exchange-traded contracts and counter derivatives transactions; and also engages in real estate operations. Its primary trade execution facilities consist of its CME Globex electronic trading platform and open outcry trading floors, as well as privately negotiated transact ions that are cleared and settled through its clearing house. In addition, the company offers market data services comprising live quotes, delayed quotes, market reports, and historical data services, as well as involves in index services business. CME Group?s customer base includes professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, and governments. It has strategic partnerships with BM&FBOVESPA S.A., Bursa Malaysia Derivatives, Singapore Exchange Limited, Green Exchange, Dubai Mercantile Exchange, Johannesburg Stock Exchange, and Bolsa Mexicana de Valores, S.A.B. de C.V., as well as joint venture agreement with Dow Jones & Company. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group was founded in 1898 and is headquartered in Chicago, Illinois.Advisors' Opinion:
- [By Eric Volkman]
CME Group (NASDAQ: CME ) is staying consistent for the moment in terms of shareholder payouts. The company has declared a dividend for its Q2 of $0.45 per share, to be paid on June 25 to shareholders of record as of June 10.�That amount matches CME Group's previous distribution, which was paid at the end of March.
- [By Russ Krull]
CME Group (NASDAQ: CME ) made a market for its own debt, selling $750 million of 5.3% 30-year paper. The money will be used to redeem $750 million of 5.75% paper maturing next February. The refi will save CME a little more than $3 million per year in debt service.
Top 5 Defensive Stocks To Buy For 2014: Genco Shipping & Trading Limited (GNK)
Genco Shipping & Trading Limited engages in the ocean transportation of drybulk cargoes through the ownership and operation of drybulk carrier vessels worldwide. It transports iron ore, coal, grain, steel products, and other drybulk cargoes. The company charters its vessels primarily to trading houses, which include commodities traders; producers; and government-owned entities. Its fleet consists of 53 drybulk carriers, including 9 Capesize, 8 Panamax, 17 Supramax, 6 Handymax, and 13 Handysize drybulk carriers with an aggregate carrying capacity of approximately 3,810,000 dwt. The company, through its subsidiary, Baltic Trading Limited, operates a fleet of two Capesize, four Supramax, and three Handysize drybulk carriers with an aggregate carrying capacity of approximately 672,000 dwt. Genco Shipping & Trading Limited was incorporated in 2004 and is based in New York, New York.Advisors' Opinion:
- [By silvmich]
This is Part Three of a series of articles published on GuruFocus outlining a short thesis against Genco Shipping and Trading (GNK). Part One was published on October 31, 2013 and Part Two was published on November 14, 2013. This Part Three provides certain updates on the situation, including recent news items, as well as a look into a number of counterarguments made against the short position.